Search research articles
Contact Us
Filters
Showing results (281-290 of 300) with videos related to
Page
of 30
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 12, 2010
NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors
George D Demetri, Margaret von Mehren, Cristina R Antonescu, et al.
Future Oncology (London, England)
|
January 30, 2019
Guidance of sentinel lymph node biopsy decisions in patients with T1-T2 melanoma using gene expression profiling
John T Vetto, Eddy C Hsueh, Brian R Gastman, et al.
Annals of Surgical Oncology
|
September 5, 2006
The effect of preoperative radiotherapy and reconstructive surgery on wound complications after resection of extremity soft-tissue sarcomas
Jennifer F Tseng, Matthew T Ballo, Howard N Langstein, et al.
Surgical Endoscopy
|
February 7, 2025
Bariatric surgery and relevant comorbidities: a systematic review and meta-analysis
Claire Wunker, Sunjay Kumar, Peter Hallowell, et al.
Journal of the American College of Surgeons
|
December 30, 2015
Training High-Volume Melanoma Surgeons to Perform a Novel Minimally Invasive Inguinal Lymphadenectomy: Report of a Prospective Multi-Institutional Trial
James W Jakub, Alicia M Terando, Amod Sarnaik, et al.
Journal of the American Academy of Dermatology
|
March 10, 2015
Gene expression profiling for molecular staging of cutaneous melanoma in patients undergoing sentinel lymph node biopsy
Pedram Gerami, Robert W Cook, Maria C Russell, et al.
Annals of Surgery
|
December 24, 2016
Safety and Feasibility of Minimally Invasive Inguinal Lymph Node Dissection in Patients With Melanoma (SAFE-MILND): Report of a Prospective Multi-institutional Trial
James W Jakub, Alicia M Terando, Amod Sarnaik, et al.
Gastroenterology
|
July 26, 2021
TVB-2640 (FASN Inhibitor) for the Treatment of Nonalcoholic Steatohepatitis: FASCINATE-1, a Randomized, Placebo-Controlled Phase 2a Trial
Rohit Loomba, Rizwana Mohseni, K Jean Lucas, et al.
BMC Cancer
|
February 7, 2018
Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients
Jonathan S Zager, Brian R Gastman, Sancy Leachman, et al.
Annals of Surgical Oncology
|
May 2, 2022
Oncologic Outcomes of Multi-Institutional Minimally Invasive Inguinal Lymph Node Dissection for Melanoma Compared with Open Inguinal Dissection in the Second Multicenter Selective Lymphadenectomy Trial (MSLT-II)
James W Jakub, Michael Lowe, J Harrison Howard, et al.
Page
of 30
Search research articles
Search
Showing results (281-290 of 300) with videos related to
Sort By:
Page
of 30
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 12, 2010
NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors
George D Demetri, Margaret von Mehren, Cristina R Antonescu, et al.
Future Oncology (London, England)
|
January 30, 2019
Guidance of sentinel lymph node biopsy decisions in patients with T1-T2 melanoma using gene expression profiling
John T Vetto, Eddy C Hsueh, Brian R Gastman, et al.
Annals of Surgical Oncology
|
September 5, 2006
The effect of preoperative radiotherapy and reconstructive surgery on wound complications after resection of extremity soft-tissue sarcomas
Jennifer F Tseng, Matthew T Ballo, Howard N Langstein, et al.
Surgical Endoscopy
|
February 7, 2025
Bariatric surgery and relevant comorbidities: a systematic review and meta-analysis
Claire Wunker, Sunjay Kumar, Peter Hallowell, et al.
Journal of the American College of Surgeons
|
December 30, 2015
Training High-Volume Melanoma Surgeons to Perform a Novel Minimally Invasive Inguinal Lymphadenectomy: Report of a Prospective Multi-Institutional Trial
James W Jakub, Alicia M Terando, Amod Sarnaik, et al.
Journal of the American Academy of Dermatology
|
March 10, 2015
Gene expression profiling for molecular staging of cutaneous melanoma in patients undergoing sentinel lymph node biopsy
Pedram Gerami, Robert W Cook, Maria C Russell, et al.
Annals of Surgery
|
December 24, 2016
Safety and Feasibility of Minimally Invasive Inguinal Lymph Node Dissection in Patients With Melanoma (SAFE-MILND): Report of a Prospective Multi-institutional Trial
James W Jakub, Alicia M Terando, Amod Sarnaik, et al.
Gastroenterology
|
July 26, 2021
TVB-2640 (FASN Inhibitor) for the Treatment of Nonalcoholic Steatohepatitis: FASCINATE-1, a Randomized, Placebo-Controlled Phase 2a Trial
Rohit Loomba, Rizwana Mohseni, K Jean Lucas, et al.
BMC Cancer
|
February 7, 2018
Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients
Jonathan S Zager, Brian R Gastman, Sancy Leachman, et al.
Annals of Surgical Oncology
|
May 2, 2022
Oncologic Outcomes of Multi-Institutional Minimally Invasive Inguinal Lymph Node Dissection for Melanoma Compared with Open Inguinal Dissection in the Second Multicenter Selective Lymphadenectomy Trial (MSLT-II)
James W Jakub, Michael Lowe, J Harrison Howard, et al.
Page
of 30